Skip to main content
. 2016 Jun 21;9:3695–3704. doi: 10.2147/OTT.S103735

Figure 2.

Figure 2

Odds ratio of all-grade venous thromboembolic events associated with antivascular endothelial growth factor (VEGF) agents vs control.

Notes: Group-A is the number of patients included for analysis in VEGF group; Group-B is the number of patients included for analysis in controlled group.

Abbreviations: CI, confidence interval; I2, level of heterogeneity among included trials.